Quinlan Steven J. 4
4 · NEOGEN CORP · Filed Apr 14, 2021
Insider Transaction Report
Form 4
NEOGEN CORPNEOG
Quinlan Steven J.
VP & CFO
Transactions
- Exercise/Conversion
Common Stock (Right to Buy)
2021-04-14−13,001→ 103,998 totalExercise: $60.43Exp: 2022-11-27→ Common Stock (13,001 underlying) - Exercise/Conversion
Common Stock
2021-04-14$60.43/sh+13,001$785,618→ 26,471 total - Sale
Common Stock
2021-04-14$93.93/sh−13,001$1,221,153→ 13,470 total
Footnotes (1)
- [F1]Options were granted on 10/27/2017, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant